Breaking News, Promotions & Moves

Emergent BioSolutions CEO Robert Kramer Sr. to Retire

Haywood Miller will serve as interim CEO.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Emergent BioSolutions’ President and CEO, Robert G. Kramer Sr., plans to retire from Emergent. Mr. Kramer will step down from his role and as a member of the board, effective immediately. The Board has appointed Haywood Miller as interim CEO while it conducts a search to identify a new permanent CEO. Mr. Miller, Managing Director at Berkeley Research Group, has served as an advisor to the Company and its executive management team for the last several months. To help ensure a smooth transition, M...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters